Evaluation shows long-term wound improvement in individuals with recessive dystrophic epidermolysis bullosa, indicating effective regenerative therapy.
The development of prademagene zamikeracel represents a significant advance in regenerative therapy for RDEB, demonstrating that durable restoration of C7 expression and long-term wound improvement can be achieved through skin grafting.
No takes yet. Share an insight, caveat, or question.
Lesiak et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: